Integral Health Asset Management, Llc
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$2.09B
Q ending 2026-03-31
Prior quarter
$2.01B
Q ending 2025-12-31
Change
+3.8% QoQ · +122.5% YoY
Positions
90
reported holdings
Largest positions
All 90 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Insmed Inc | INSM | Shares | $245.3M | 1.5M |
| Revolution Medicines Inc | RVMD | Shares | $145.9M | 1.5M |
| Cytokinetics Inc | CYTK | Shares | $105.5M | 1.6M |
| Revolution Medicines Inc | RVMD | Put | $72.9M | 750K |
| Cytokinetics Inc | CYTK | Call | $65.9M | 1.0M |
| Regeneron Pharmaceuticals | REGN | Shares | $65.7M | 85K |
| Vera Therapeutics Inc | VERA | Shares | $64.4M | 1.6M |
| Cardinal Health Inc | CAH | Shares | $57.1M | 270K |
| Roivant Sciences Ltd | Shares | $55.4M | 2.0M | |
| Brightspring Health Svcs Inc | BTSG | Shares | $53.3M | 1.3M |
| Rhythm Pharmaceuticals Inc | RYTM | Shares | $52.2M | 600K |
| Merck & Co Inc | MRK | Shares | $51.1M | 425K |
| Edgewise Therapeutics Inc | EWTX | Shares | $50.4M | 1.6M |
| Astrazeneca Plc | Shares | $49.3M | 250K | |
| Revolution Medicines Inc | RVMD | Call | $48.6M | 500K |
| Alignment Healthcare Inc | ALHC | Shares | $45.4M | 2.6M |
| Novartis Ag | NVS | Shares | $38.2M | 250K |
| Boston Scientific Corp | BSX | Shares | $34.5M | 550K |
| Lifestance Health Group Inc | LFST | Shares | $27.4M | 4.3M |
| Ascendis Pharma A/S | Shares | $26.3M | 115K | |
| Scholar Rock Hldg Corp | SRRK | Shares | $24.6M | 500K |
| Elevance Health Inc Formerly | ELV | Shares | $22.0M | 75K |
| Centene Corp Del | CNC | Shares | $21.3M | 650K |
| Bridgebio Pharma Inc | BBIO | Shares | $20.4M | 275K |
| Mineralys Therapeutics Inc | MLYS | Shares | $20.3M | 750K |
| Neurocrine Biosciences Inc | NBIX | Shares | $19.8M | 150K |
| Glaukos Corp | GKOS | Shares | $18.8M | 175K |
| Arrowhead Pharmaceuticals In | ARWR | Shares | $18.8M | 300K |
| Vertex Pharmaceuticals Inc | VRTX | Shares | $17.9M | 40K |
| Oric Pharmaceuticals Inc | ORIC | Shares | $17.7M | 1.4M |
| Alumis Inc | ALMS | Shares | $17.6M | 800K |
| Fresenius Medical Care Ag | FMS | Shares | $17.5M | 775K |
| Intuitive Surgical Inc | ISRG | Shares | $16.1M | 35K |
| Uniqure Nv | Shares | $14.7M | 900K | |
| Tarsus Pharmaceuticals Inc | TARS | Shares | $14.0M | 200K |
| Gilead Sciences Inc | GILD | Shares | $13.9M | 100K |
| Eli Lilly & Co | LLY | Shares | $13.8M | 15K |
| Edwards Lifesciences Corp | EW | Shares | $13.6M | 170K |
| Mineralys Therapeutics Inc | MLYS | Call | $13.5M | 500K |
| Cogent Biosciences Inc | COGT | Shares | $13.5M | 350K |
| Elanco Animal Health Inc | ELAN | Shares | $13.2M | 550K |
| Madrigal Pharmaceuticals Inc | MDGL | Shares | $13.1M | 25K |
| Praxis Precision Medicines I | PRAX | Shares | $12.9M | 40K |
| Dianthus Therapeutics Inc | DNTH | Shares | $12.6M | 150K |
| Regenxbio Inc | RGNX | Shares | $12.6M | 1.5M |
| Quest Diagnostics Inc | DGX | Shares | $11.8M | 60K |
| Xenon Pharmaceuticals Inc | XENE | Shares | $11.6M | 200K |
| Erasca Inc | ERAS | Shares | $11.3M | 700K |
| Alto Neuroscience Inc | ANRO | Shares | $11.2M | 500K |
| Biogen Inc | BIIB | Shares | $11.0M | 60K |
| Dexcom Inc | DXCM | Shares | $11.0M | 175K |
| Soleno Therapeutics Inc | SLNOEUR | Shares | $10.9M | 325K |
| Disc Medicine Inc | IRON | Shares | $10.9M | 170K |
| Nurix Therapeutics Inc | NRIX | Shares | $10.8M | 700K |
| Cvs Health Corp | CVS | Shares | $10.8M | 150K |
| Cooper Cos Inc | COO | Shares | $10.7M | 150K |
| Thermo Fisher Scientific Inc | TMO | Shares | $9.8M | 20K |
| Livanova Plc | Shares | $9.5M | 150K | |
| Lantheus Hldgs Inc | LNTH | Shares | $9.5M | 125K |
| Tango Therapeutics Inc | TNGX | Shares | $9.4M | 450K |
| Ionis Pharmaceuticals Inc | IONS | Shares | $9.4M | 125K |
| Sana Biotechnology Inc | SANA | Shares | $9.2M | 3.2M |
| Celcuity Inc | CELC | Shares | $9.1M | 80K |
| Protara Therapeutics Inc | TARA | Shares | $9.1M | 1.8M |
| Envista Holdings Corporation | NVST | Shares | $8.9M | 350K |
| Biohaven Ltd | Shares | $8.5M | 1.0M | |
| Syndax Pharmaceuticals Inc | SNDX | Shares | $8.2M | 350K |
| Viking Therapeutics Inc | VKTX | Shares | $8.1M | 250K |
| Definium Therapeutics Inc | DFTX | Shares | $7.6M | 400K |
| Beam Therapeutics Inc | BEAM | Shares | $7.1M | 300K |
| Rezolute Inc | RZLT | Shares | $6.1M | 2.0M |
| Capricor Therapeutics Inc | CAPR | Shares | $6.1M | 200K |
| Iqvia Hldgs Inc | IQV | Shares | $6.0M | 35K |
| Axsome Therapeutics Inc. | AXSM | Shares | $5.9M | 35K |
| Protagonist Therapeutics Inc | PTGX | Shares | $5.3M | 50K |
| Evommune Inc | EVMN | Shares | $5.2M | 225K |
| Acadia Healthcare Company In | ACHC | Shares | $4.7M | 200K |
| Zimmer Biomet Holdings Inc | ZBH | Shares | $4.5M | 50K |
| Forte Biosciences Inc | FBRX | Shares | $3.9M | 150K |
| Lb Pharmaceuticals Inc | LBRX | Shares | $3.7M | 150K |
| Savara Inc | SVRA | Shares | $3.3M | 600K |
| Relmada Therapeutics Inc | RLMD | Shares | $3.1M | 450K |
| Immunocore Hldgs Plc | IMCR | Shares | $3.0M | 100K |
| Maze Therapeutics Inc | MAZE | Shares | $3.0M | 100K |
| Tenax Therapeutics Inc | TENX | Shares | $2.7M | 167K |
| Inhibikase Therapeutics Inc | IKT | Shares | $2.3M | 1.4M |
| Olema Pharmaceuticals Inc | OLMA | Shares | $2.2M | 150K |
| Inventiva Sa | IVA | Shares | $2.2M | 400K |
| Sionna Therapeutics Inc | SION | Shares | $2.0M | 50K |
| Unicycive Therapeutics Inc | UNCY | Shares | $1.5M | 225K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.